213 related articles for article (PubMed ID: 24699315)
1. miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
Lu L; Byrnes K; Han C; Wang Y; Wu T
Mol Cancer Res; 2014 Jun; 12(6):890-900. PubMed ID: 24699315
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
Yao L; Han C; Song K; Zhang J; Lim K; Wu T
Cancer Res; 2015 Apr; 75(7):1388-98. PubMed ID: 25691459
[TBL] [Abstract][Full Text] [Related]
3. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.
Lu D; Han C; Wu T
J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
5. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.
Shu L; Li X; Liu Z; Li K; Shi A; Tang Y; Zhao L; Huang L; Zhang Z; Zhang D; Huang S; Lian S; Sheng G; Yan Z; Zhang Z; Xu Y
Hepatology; 2024 Feb; 79(2):307-322. PubMed ID: 37140231
[TBL] [Abstract][Full Text] [Related]
6. miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
Zhu H; Han C; Lu D; Wu T
Am J Pathol; 2014 Oct; 184(10):2828-39. PubMed ID: 25239565
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
9. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
[TBL] [Abstract][Full Text] [Related]
10. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
12. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.
Zhang J; Han C; Wu T
Gastroenterology; 2012 Jul; 143(1):246-56.e8. PubMed ID: 22484120
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.
Olaru AV; Ghiaur G; Yamanaka S; Luvsanjav D; An F; Popescu I; Alexandrescu S; Allen S; Pawlik TM; Torbenson M; Georgiades C; Roberts LR; Gores GJ; Ferguson-Smith A; Almeida MI; Calin GA; Mezey E; Selaru FM
Hepatology; 2011 Dec; 54(6):2089-98. PubMed ID: 21809359
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
17. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
[TBL] [Abstract][Full Text] [Related]
18. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.
Loeffler MA; Hu J; Kirchner M; Wei X; Xiao Y; Albrecht T; De La Torre C; Sticht C; Banales JM; Vogel MN; Pathil-Warth A; Mehrabi A; Hoffmann K; Rupp C; Köhler B; Springfeld C; Schirmacher P; Ji J; Roessler S; Goeppert B
J Pathol; 2020 Nov; 252(3):239-251. PubMed ID: 32710569
[TBL] [Abstract][Full Text] [Related]
19. miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).
Zhang J; Han C; Zhu H; Song K; Wu T
Am J Pathol; 2013 May; 182(5):1629-39. PubMed ID: 23608225
[TBL] [Abstract][Full Text] [Related]
20. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
